Lab to Label: Translating Clinical Evidence into Regulatory & Product Labelling

This comprehensive training program focuses on the end-to-end journey of pharmaceutical data from early research to approved product labelling. The course helps professionals understand how scientific evidence generated during drug discovery, nonclinical development, and clinical trials is translated into regulatory documents and ultimately into approved product labels. Participants will explore regulatory writing requirements for IND submissions, clinical development documentation, CTD modules, and global labelling documents such as USPI, SmPC, and CCDS. Through practical case studies and writing simulations, the program equips participants with the ability to transform complex scientific data into clear, compliant, and submission-ready regulatory documentation.